Literature DB >> 109895

Tolerance to amphetamine-induced impairment of rotarod performance in rats.

M C Gerald, T K Gupta, R M Snider.   

Abstract

Acute administration of d-amphetamine sulfate (30 mg/kg, i.p.) caused muscle weakness and 80% failure in rotarod performance in rats. The incidence of performance failure progressively decreased to 30% in animals receiving d-amphetamine and tested daily for 8 days. A similar progressive reduction in performance impairment was observed in animals receiving d-amphetamine for 3, 5, or 7 days (12.5%) and evaluated only once after the last dose. The tolerance is attributable to a physiological or biochemical rather than learning phenomenon.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109895     DOI: 10.1007/bf00432278

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  3 in total

1.  The effects of amphetamine isomers on rotarod performance.

Authors:  M C Gerald; T K Gupta
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

2.  Curare-like effects of the amphetamine isomers on neuromuscular transmission.

Authors:  K A Skau; M C Gerald
Journal:  Neuropharmacology       Date:  1978 Apr-May       Impact factor: 5.250

3.  Acute and chronic effects of d- and 1-amphetamine on seizure susceptibility in mice.

Authors:  M C Gerald; W H Riffee
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

  3 in total
  2 in total

Review 1.  Behavioural tolerance to amphetamine and other psychostimulants: the case for considering behavioural mechanisms.

Authors:  C Demellweek; A J Goudie
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

2.  The antipsychotic drug, fluphenazine, effectively reverses mechanical allodynia in rat models of neuropathic pain.

Authors:  Xiao-Wei Dong; Yuping Jia; Sherry X Lu; Xiaoping Zhou; Mary Cohen-Williams; Robert Hodgson; Huiqing Li; Tony Priestley
Journal:  Psychopharmacology (Berl)       Date:  2007-09-23       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.